Medicinal Products

Mircera

Name Mircera
Active Substance methoxy polyethylene glycol-epoetin beta
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code B03XA03
Medicinal product marketed in the Croatia Da
Educational materials
for healthcare professionals
Vodič za liječnike, verzija 2

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/mircera

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o novim upozorenjima o teškim kožnim nuspojavama lijekova koji sadrže humane epoetine 29.09.2017 Amgen d.o.o., Pfizer Croatia d.o.o., Pliva Hrvatska d.o.o., Roche d.o.o. i Sandoz d.o.o.
Back